Cyanoamidine Cyclization Approach to Remdesivir's Nucleobase.
Org Lett
; 22(21): 8430-8435, 2020 11 06.
Article
in English
| MEDLINE | ID: covidwho-882861
ABSTRACT
We report an alternative approach to the unnatural nucleobase fragment seen in remdesivir (Veklury). Remdesivir displays broad-spectrum antiviral activity and is currently being evaluated in Phase III clinical trials to treat patients with COVID-19. Our route relies on the formation of a cyanoamidine intermediate, which undergoes Lewis acid-mediated cyclization to yield the desired nucleobase. The approach is strategically distinct from prior routes and could further enable the synthesis of remdesivir and other small-molecule therapeutics.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Adenosine Monophosphate
/
Alanine
/
Amidines
Type of study:
Experimental Studies
/
Prognostic study
Language:
English
Journal:
Org Lett
Journal subject:
Biochemistry
Year:
2020
Document Type:
Article
Affiliation country:
Acs.orglett.0c03052
Similar
MEDLINE
...
LILACS
LIS